

%201.webp)


%201.webp)




LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。



%201.webp)


%201.webp)




序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

Rwanda has established a national framework for pharmaceutical traceability under the Rwanda Food and Drugs Authority (Rwanda FDA). The system is designed to improve medicine safety, strengthen supply chain visibility, and reduce the risk of falsified medicines in the market.
The regulatory framework requires the use of global identification standards and structured data sharing across the pharmaceutical supply chain. Rwanda’s traceability strategy is built on GS1 standards and includes product identification, location identification, and master data governance through a national product catalogue.
Manufacturers, importers, distributors, and supply chain partners must implement standardized identification and data capture processes to support product traceability from manufacturer to healthcare facilities.
Pharmaceutical products supplied to Rwanda must support standardized identification aligned with GS1 standards.
Key identification elements include:
The barcode used for pharmaceutical identification should support machine readable data capture and interoperability across supply chain systems.
Location identification must use Global Location Numbers (GLN) to uniquely identify supply chain actors such as manufacturers, importers, distributors, warehouses, and healthcare facilities.
Human readable information printed on packaging must match the encoded barcode data.
2018 – Rwanda Food and Drugs Authority established under national legislation governing regulation of medicines and health products.
2022 – Rwanda FDA issued regulations governing identification, data capture, and data sharing for pharmaceutical traceability.
2022 August– National guidelines for pharmaceutical product identification and labelling issued.
2022 August– Guidelines for product and location master data sharing issued to support the National Product Catalogue.
2023 onward – Implementation of standardized identification and data sharing across pharmaceutical supply chain stakeholders.
The framework ensures that traceability information can be accessed during regulatory inspections, investigations, and product recalls.
Rwanda operates a National Product Catalogue (NPC) that serves as the central reference system for pharmaceutical product and location master data.
The NPC stores standardized information including:
The catalogue enables consistent product identification across procurement systems, regulatory authorities, and supply chain stakeholders.
The national traceability framework supports data exchange and interoperability between supply chain systems using standardized identifiers and structured data.
The Rwanda traceability framework supports packaging hierarchy identification and traceability across supply chain levels.
While a nationwide mandatory aggregation hierarchy is not explicitly defined for all pharmaceutical products, companies supplying the market are expected to support packaging level identification and traceability where required by supply chain operations.
Logistics units such as cases or pallets may use SSCC identifiers to enable tracking of shipment units across distribution channels.
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.